Gregory Brill

Patterns of Initiation of Oral Anticoagulants in Patients with Atrial Fibrillation— Quality and Cost Implications

Nihar R. Desai, Alexis A. Krumme, Sebastian Schneeweiß et al. · The American Journal of Medicine · 2014 · 204 citations · Full text

Medicine, Cardiology, Pharmacoeconomics +12

Trouble Getting Started: Predictors of Primary Medication Nonadherence

Michael A. Fischer, Niteesh K. Choudhry, Gregory Brill et al. · The American Journal of Medicine · 2011 · 166 citations

Pharmacy, Pharmacotherapy, Pharmacy Practice +8

Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions

Shirley Wang, Sushama Kattinakere Sreedhara, Sebastian Schneeweiß et al. · Nature Communications · 2022 · 102 citations · Full text

Pharmacy, Pharmacoeconomics, Evidence-based Practice +15

Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013–2018

Chintan V. Dave, Sebastian Schneeweiß, Deborah J. Wexler et al. · Diabetes Care · 2020 · 101 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study

Eun Ha Kang, Yinzhu Jin, Gregory Brill et al. · Journal of the American Heart Association · 2018 · 75 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17